28 results on '"Compare, D"'
Search Results
2. T.08.2: BEVACIZUMAB AS A RESCUE THERAPY IN PATIENTS WITH SMALL BOWEL ANGIOECTASIAS BLEEDING REFRACTORY TO STANDARD TREATMENTS.
3. AF.95 VALIDATION OF COMBINED NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATIO (CNP) SCORE AS PREDICTOR FOR RECURRENCE FOLLOWING RADIOFREQUENCY ABLATION OF HEPATOCELLULAR CARCINOMA.
4. AF.73 DIFFUSE GASTROINTESTINAL MALT LYMPHOMA IN A PATIENT WITH ULCERATIVE COLITIS IN REMISSION.
5. OC.05.7 BLINDED ORAL CHALLENGES WITH LACTOSE AND PLACEBO ACCURATELY DIAGNOSE LACTOSE INTOLERANCE: A REAL-LIFE STUDY.
6. Interleukin-13 mucosal production in Helicobacter pylori-related gastric diseases.
7. OC.05.8 ENDOSCOPIC PREDICTORS OF RESPONSE TO OCTREOTIDE THERAPY FOR GASTROINTESTINAL BLEEDING DUE TO SMALL BOWEL ANGIOECTASIAS.
8. P.01.18 A REAL LIFE OBSERVATIONAL STUDY ON THE ERADICATION OF H. PYLORI INFECTION IN PATIENTS NAÏVE TO TREATMENT USING CONCOMITANT THERAPY OR BISMUTH QUADRUPLE THERAPY (THREE-IN-ONE PILL).
9. P.09.7: Mucosal GUT Microbiota Composition in Patients with HCV Infection, from Chronic Hepatitis to Hepatocellular Carcinoma.
10. P.09.15: Virological Response Improves Liver Function Assessed by 13C-Aminopyrine Breath Test in Patients with HCV-Related Advanced Liver Disease.
11. P.03.15: Lactobacillus Casei DG and its Postbiotic Reduce the Inflammatory Mucosal Response: An Ex-Vivo Organ Culture Model of Post-Infectious Irritable Bowel Syndrome.
12. OC.09.5: Adherence to Guidelines for Helicobacter Pylori Infection Testing and Treating in a Southern Italy Area.
13. P.09.16: Disparate Access to New Antiviral Treatment Regimens Affects Quality of Life in HCV-Infected Patients.
14. PANTOPRAZOLE AND RABEPRAZOLE DO NOT IMPACT THE ACTIVITY OF CYTOCHROME P450 ASSESSED BY [13 C]-AMINOPYRINE BREATH TEST IN PATIENTS WITH LIVER CIRRHOSIS.
15. “EARLY” SUBCLINICAL LEFT VENTRICULAR DISFUNCTION IN PATIENTS WITH HEPATITIS C VIRUS INFECTION.
16. OC.21.5 LAR OCTREOTIDE IS EFFECTIVE IN CONTROLLING RECURRENT BLEEDING FROM GASTROINTESTINAL ANGIODYSPLASIAS: A RETROSPECTIVE STUDY OF 98 CASES.
17. P.03.10 VITAMIN B12 SUPPLEMENTATION IMPROVES SUSTAINED-VIRAL-RESPONSE RATES IN HEPATITIS C VIRUS GENOTYPE 1B-INFECTED PATIENTS.
18. OC.07.5 HCV-ANTIVIRAL THERAPY DELAYS GASTRIC EMPTYING TIME AND MODIFIES CCK AND MOTILIN SERUM LEVELS.
19. OC.04.2: P-GP REGULATES APOPTOSIS IN GASTRIC MUCOSA BY INTERACTING WITH BCL-XL: AN IN VIVO AND IN VITRO STUDY.
20. P.150 A RAT MODEL OF OXIDATIVE AND METABOLIC HEPATIC INJURY: THE POTENTIAL PROTECTIVE ROLE OF LACTOBACILLUS PARACASEI F19.
21. P.125 13C-AMINOPYRINE BREATH TEST PREDICTS THE CLINICAL OUTCOME IN PATIENTS WITH C VIRUS-RELATED CHRONIC HEPATITIS.
22. P.102 IDENTIFICATION AND CHARACTERIZATION OF CANCER STEM CELLS IN PRIMARY HUMAN GASTRIC CANCER.
23. P.100 GASTRIC CANCER BIOLOGICAL BEHAVIOUR: FROM BIOINFORMATIC HYPOTHESIS TO MOLECULAR ANALYSIS.
24. P.99 DNA HYPOMETHYLATION IS AN EARLY EVENT IN HP-RELATED GASTRIC CARCINOGENESIS.
25. P.44 INTRA-INDIVIDUAL REPRODUCIBILITY OF THE GLUCOSE HYDROGEN BREATH TEST IN A COHORT OF HEALTHY SUBJECTS.
26. OC.11.2 EXPRESSION OF INTERLEUKIN IL-13 RECEPTOR IN HELICOBACTER PYLORI-RELATED GASTRIC DISEASES.
27. COX-2 AND NF-κB EXPRESSION IN INFLAMED GASTRIC MUCOSA IS INFLUENCED BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA POLYMORPHISMS.
28. Molecular pathways and interleukin (IL)-13 role in the modulation of inflammatory response during H. pylori infection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.